SCHEMBL30398147

SCHEMBL30398147

Brc1cncc(-c2nnc3ccccn23)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.53
HSD17B10 Q99714 3/20 0.53
KMT2A Q03164 1/20 0.53
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP11B2 P19099 1/20 0.44
MAPK1 P28482 2/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.39
MAPT P10636 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
GSK3B P49841 2/20 0.38
CYP2A6 P11509 2/20 0.38
PIM1 P11309 4/20 0.38
PIM2 Q9P1W9 4/20 0.38
PTK2 Q05397 1/20 0.36
NT5E P21589 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25417102 1.00 KDM4E (0.53) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL25419836 0.82 KDM4E (0.53) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL30396864 0.82 KDM4E (0.53) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL6219388 0.75 KDM4E (0.73) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL23458576 0.74 KDM4E (0.67) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL25421165 0.73 KDM4E (0.53) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL30498956 0.71 KDM4E (0.58) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL22322737 0.70 KDM4E (0.57) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL30498960 0.69 KDM4E (1.00) KDM4EHSD17B10KMT2AALDH1A1HPGD
SCHEMBL2021844 0.69 ALDH1A1 (0.43) KDM4EHSD17B10KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed